We are live on
!
Find out more
OASM
Oasmia Pharmaceutical AB
OASM
OASM
Delisted
OASM was delisted on the 21st of August, 2019.
4 hedge funds and large institutions have $49K invested in Oasmia Pharmaceutical AB in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
33% less funds holding
Funds holding: 6 → 4 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
78% less capital invested
Capital invested by funds: $226K → $49K (-$177K)
Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$24.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$700 |
Top Sellers
| 1 |
SCM
Sio Capital Management
New York
|
-$179K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$17K |
| 3 |
Bank of New York Mellon
New York
|
-$12K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.3K |